FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190390010> ?p ?o ?g. }

• W3190390010 endingPage "2239" @default.
• W3190390010 startingPage "2237" @default.
• W3190390010 abstract "To the Editor: Obstructive sleep apnea (OSA) is a common sleep-disordered breathing. Previous studies reported that the incidence of daytime hypercapnia in patients with OSA was 26.2% in China[1] and 14% in Japan.[2] However, Weitzenblum et al[3] demonstrated that daytime hypercapnia in patients with OSA might not be secondary to sleep apneas/hypopneas, but might due to the comorbidities, such as chronic obstructive pulmonary disease or severe obesity. Obesity hypoventilation syndrome (OHS) is defined as a conjunction of obesity (body mass index [BMI] ≥30 kg/m2), daytime hypercapnia (partial pressure of carbon dioxide in arterial blood [PaCO2] ≥45 mmHg) and sleep disordered breathing, after excluding other causes for alveolar hypoventilation.[4] Since patients with OHS were not completely excluded in previous studies,[1,2] we assumed that the incidence of daytime hypercapnia in Chinese patients with OSA might be low. Nearly 90% of patients with OHS have an associated OSA.[4] However, patients with OHS have higher rates of morbidity and mortality than patients with OSA.[4] Consequently, the differential diagnosis between OSA and OHS is very important, and daytime hypercapnia is the key index for that, especially for obese patients with OSA. Hence, it is necessary to analyze the clinical characters of OSA patients with daytime hypercapnia. This retrospective study was performed from January 2013 to February 2021 in the sleep unit of our hospital. We included adult patients (age ≥18 years) with data on polysomnography, pulmonary function, and arterial blood analysis. We excluded participants if the apnea-hypopnea index (AHI) was <5/h, central/mixed apnea/hypopnea was the primary suspicion, or the ratio of forced expiratory volume in 1 s (FEV1) to the forced vital capacity (FVC) (FEV1/FVC) was <70% or percentages of predicted FEV1 and FVC were <80%, except due to obesity. Finally, we recruited 294 participants in this study [Supplementary Figure 1, https://links.lww.com/CM9/A640]. The study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee of Peking Union Medical College Hospital (No. S-K567) (Trial registration: ChiCTR1800019159). The full night polysomnography was performed with Embla N7000 (Natus Medical Incorporated, Broomfield, CO, USA) and was reviewed for analysis by an experienced sleep investigator. We scored respiratory events as stated in the 2017 American Academy of Sleep Medicine criteria. We determined nocturnal hypoxemia by oxygen desaturation index (ODI), minimum values of arterial oxygen saturation (SaO2), mean values of SaO2, and the percentage of time spent at oxygen saturation below 90% in total sleep time (SIT90%) during sleep. Pulmonary function tests were performed to determine the FEV1/FVC and the percentage of predicted FEV1 and FVC using a standard spirometer (MS-IOS, Jaeger, Hoechberg, Germany). Arterial blood was drawn when the patients were in the sitting position and breathed room air. The arterial blood gas analyzer (ABL800, Radiometer, Copenhagen, Denmark) was used to analyze potential of hydrogen, partial pressure of oxygen (PaO2), PaCO2, SaO2, and bicarbonate. The data of arterial blood gas analysis that were closest to the time of polysomnography were collected. Hypercapnia was defined as PaCO2 ≥45 mmHg. The SPSS software (version 21.0, Chicago, IL, USA) was used. Quantitative data are expressed as mean ± standard deviation or median (interquartile range), according to data distribution. Distribution of the variables was analyzed with the Shapiro-Wilk test. Qualitative data were expressed as counts and percentages. The statistical differences between two groups were tested with independent samples t-test or Mann-Whitney U test for whether the data were normally distributed, and Pearson χ2 test for qualitative data. Univariate analyses and multiple forward stepwise logistic regression analyses (likelihood ratio) were applied to explore possible factors that were associated with daytime hypercapnia. P < 0.05 was considered statistically significant. The prevalence of daytime hypercapnia was 8.16% (24/294) in the study population. OHS was diagnosed in 58.33% of hypercapnic patients (14/24). Thus, the incidence of daytime hypercapnia was 3.57% (10/280) in patients with OSA. As shown in Table 1, gender, age, BMI, FEV1/FVC ratio, and AHI were not significantly different between the two groups. Compared with eucapnic patients, hypercapnic patients had lower percentages of predicted FEV1 and FVC, lower daytime PaO2 and SaO2, higher bicarbonate level, and a worse degree of nocturnal hypoxia, expressed as higher ODI and SIT90%, and lower minimum SaO2 and mean SaO2. In the multivariable adjusted model, the bicarbonate and percentage of predicted FVC, adjusted by gender, BMI, ODI, minimum SaO2, mean SaO2, SIT90%, PaO2, and percentage of predicted FEV1, were significantly associated with daytime hypercapnia [Supplementary Table 1, https://links.lww.com/CM9/A640]. Table 1 - Comparison between eucapnic and hypercapnic patients with OSA. Items PaCO2 <45 mmHg (n = 270) PaCO2 ≥45 mmHg (n = 24) P Male 224 (82.96) 23 (95.83) 0.174 Age, years 42.0 (34.0–53.3) 48.0 (41.0–53.8) 0.163 BMI, kg/m2 28.73 (25.95–31.65) 30.75 (26.90–33.27) 0.188 FEV1 predicted 96.05 (88.18–103.03) 87.05 (81.05–100.65) 0.006 FVC, % predicted 98.50 (90.48–105.93) 90.80 (82.30–98.83) 0.004 FEV1/FVC 80.37 ± 4.56 80.38 ± 4.74 0.995 AHI, /h 33.35 (15.08–60.75) 55.70 (25.98–80.75) 0.056 ODI, /h 25.35 (11.63–54.90) 61.10 (16.45–83.28) 0.021 Nighttime minimum SaO2 82.00 (74.00–87.00) 75.00 (58.00–86.75) 0.017 Nighttime mean SaO2 96.00 (93.90–97.30) 92.70 (84.68–96.75) 0.003 SIT90% 2.10 (0.10–9.43) 14.70 (0.15–64.00) 0.018 PH 7.402 ± 0.020 7.384 ± 0.017 <0.001 PaO2, mmHg 89.55 (83.23–96.73) 85.00 (71.53–93.00) 0.029 Daytime saO2 97.10 (96.40–97.60) 96.30 (94.23–97.08) <0.001 PaCO2, mmHg 39.65 (38.00–41.25) 46.00 (45.55–47.00) <0.001 Bicarbonate, mmol/L 24.084 ± 1.195 26.879 ± 1.298 <0.001 Data are presented as mean ± standard deviation, median (interquartile range) or n (%). AHI: Apnea-hypopnea index; BMI: Body mass index; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity; FEV1/FVC: Ratio of FEV1 to FVC; AHI: Apnea-hypopnea index; ODI: Oxygen desaturation index; SaO2: Oxygen saturation; SIT90%: The percentage of time spent at oxygen saturation below 90% in total sleep time; PaO2: Partial pressure of oxygen; PH: Potential of hydrogen potential of hydrogen; PaCO2: Partial pressure of carbon dioxide in arterial blood; OSA: Obstructive sleep apnea. In this study, the prevalence of daytime hypercapnia in Chinese patients with OSA was lower than that of patients in previous studies in Asia (3.57% vs. 14%–26.2%).[1,2] In patients with OSA, the daytime hypercapnia might be associated with impaired post-event ventilatory response during sleep and the increased bicarbonate level over time.[5] In this study, higher bicarbonate was the best predictor of daytime hypercapnia (odds ratio: 6.533, 95% confidence interval: 3.325–12.837). The incidence of daytime hypercapnia was 5.56% (10/180) in non-obese patients with OSA (BMI <30 kg/m2) in this study. The prognosis of non-obese patients with OSA with daytime hypercapnia was unclear. Intermittent hypoxia, an important pathophysiological feature of OSA, is the key mechanism of metabolic and cardiovascular complications. Compared with eucapnic patients, hypercapnic patients had lower daytime PaO2 and SaO2 and a worse degree of nocturnal hypoxia. Hence, patients with OSA with daytime hypercapnia might have a poor prognosis. Several limitations existed in this study. First, this retrospective study did not analyze the other pathophysiological features, complications, and prognosis of OSA. Thus, further studies are needed to explore the mechanisms and prognosis of patients with OSA with daytime hypercapnia. Second, the screening of pulmonary function and arterial blood analysis were not common for patients with OSA; therefore, a lot of patients were not included, which resulted in the small sample size. Hence, the large-scale, multicenter, prospective studies are needed to confirm these results. Funding This work was supported by grant from the National Key Technology Research and Development Project (No. 2013BAI09B10) from the Ministry of Science and Technology of China. Conflicts of interest None." @default.
• W3190390010 created "2021-08-16" @default.
• W3190390010 creator A5020404018 @default.
• W3190390010 creator A5045329653 @default.
• W3190390010 creator A5066344986 @default.
• W3190390010 creator A5074628946 @default.
• W3190390010 creator A5086132799 @default.
• W3190390010 date "2021-08-02" @default.
• W3190390010 modified "2023-09-25" @default.
• W3190390010 title "Daytime hypercapnia in adult patients with obstructive sleep apnea in China" @default.
• W3190390010 cites W2081943843 @default.
• W3190390010 cites W2103722191 @default.
• W3190390010 cites W2189174860 @default.
• W3190390010 cites W2964773226 @default.
• W3190390010 doi "https://doi.org/10.1097/cm9.0000000000001602" @default.
• W3190390010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8478380" @default.
• W3190390010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34343149" @default.
• W3190390010 hasPublicationYear "2021" @default.
• W3190390010 type Work @default.
• W3190390010 sameAs 3190390010 @default.
• W3190390010 citedByCount "1" @default.
• W3190390010 countsByYear W31903900102023 @default.
• W3190390010 crossrefType "journal-article" @default.
• W3190390010 hasAuthorship W3190390010A5020404018 @default.
• W3190390010 hasAuthorship W3190390010A5045329653 @default.
• W3190390010 hasAuthorship W3190390010A5066344986 @default.
• W3190390010 hasAuthorship W3190390010A5074628946 @default.
• W3190390010 hasAuthorship W3190390010A5086132799 @default.
• W3190390010 hasBestOaLocation W31903900101 @default.
• W3190390010 hasConcept C126322002 @default.
• W3190390010 hasConcept C127313418 @default.
• W3190390010 hasConcept C162725370 @default.
• W3190390010 hasConcept C164705383 @default.
• W3190390010 hasConcept C2776006263 @default.
• W3190390010 hasConcept C2777037550 @default.
• W3190390010 hasConcept C2777935920 @default.
• W3190390010 hasConcept C2778553927 @default.
• W3190390010 hasConcept C2781326671 @default.
• W3190390010 hasConcept C42219234 @default.
• W3190390010 hasConcept C71924100 @default.
• W3190390010 hasConcept C91586092 @default.
• W3190390010 hasConceptScore W3190390010C126322002 @default.
• W3190390010 hasConceptScore W3190390010C127313418 @default.
• W3190390010 hasConceptScore W3190390010C162725370 @default.
• W3190390010 hasConceptScore W3190390010C164705383 @default.
• W3190390010 hasConceptScore W3190390010C2776006263 @default.
• W3190390010 hasConceptScore W3190390010C2777037550 @default.
• W3190390010 hasConceptScore W3190390010C2777935920 @default.
• W3190390010 hasConceptScore W3190390010C2778553927 @default.
• W3190390010 hasConceptScore W3190390010C2781326671 @default.
• W3190390010 hasConceptScore W3190390010C42219234 @default.
• W3190390010 hasConceptScore W3190390010C71924100 @default.
• W3190390010 hasConceptScore W3190390010C91586092 @default.
• W3190390010 hasIssue "18" @default.
• W3190390010 hasLocation W31903900101 @default.
• W3190390010 hasLocation W31903900102 @default.
• W3190390010 hasLocation W31903900103 @default.
• W3190390010 hasLocation W31903900104 @default.
• W3190390010 hasLocation W31903900105 @default.
• W3190390010 hasOpenAccess W3190390010 @default.
• W3190390010 hasPrimaryLocation W31903900101 @default.
• W3190390010 hasRelatedWork W1995527129 @default.
• W3190390010 hasRelatedWork W2059569712 @default.
• W3190390010 hasRelatedWork W2089884582 @default.
• W3190390010 hasRelatedWork W2327331280 @default.
• W3190390010 hasRelatedWork W2350226251 @default.
• W3190390010 hasRelatedWork W2498720275 @default.
• W3190390010 hasRelatedWork W3030704060 @default.
• W3190390010 hasRelatedWork W3094670490 @default.
• W3190390010 hasRelatedWork W3132630958 @default.
• W3190390010 hasRelatedWork W4386098757 @default.
• W3190390010 hasVolume "134" @default.
• W3190390010 isParatext "false" @default.
• W3190390010 isRetracted "false" @default.
• W3190390010 magId "3190390010" @default.
• W3190390010 workType "article" @default.